A Pilot Study to Explore the Role of Gut Flora in Fatty Liver
NCT04160949 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Fatty Liver.
Conditions
Interventions
- OTHER
-
No Intervention
There is no intervention for this study.
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
The Effect of a Probiotic on Hepatic Steatosis
NCT00099723 ·Status: TERMINATED ·Phase: PHASE1
-
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
NCT05821010 ·Status: RECRUITING ·Phase: PHASE2
-
Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
NCT02255617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Probiotics on Non Alcoholic Fatty Liver Disease
NCT00808990 ·Status: TERMINATED ·Phase: PHASE1
-
Intestinal Microbiome Composition in Infants With Biliary Atresia (BA)
NCT03890536 ·Status: WITHDRAWN
-
Quality of Life and Nutritional Improvements in Cirrhotic Patients
NCT01842113 ·Status: TERMINATED ·Phase: PHASE4
-
Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study
NCT02366052 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
NCT01846806 ·Status: TERMINATED ·Phase: NA
-
Modulation of Secondary Bile Acids Through the Intestinal Microbiota After Consumption of a High-protein Diet.
NCT05906641 ·Status: COMPLETED ·Phase: NA
-
SMOFLipid in Patients Who Are Intralipid Intolerant
NCT03054948 ·Status: WITHDRAWN ·Phase: PHASE4
-
Cholestasis Reversal: Efficacy of IV Fish Oil
NCT00910104 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Synbiotics Interventions for Managing Cirrhosis and Its Complications
NCT05687409 ·Status: COMPLETED ·Phase: PHASE4
-
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)
NCT06352697 ·Status: COMPLETED ·Phase: NA
-
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
NCT01791959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Omegaven Protocol:Intermediate Size Patient Population
NCT03561194 ·Status: APPROVED_FOR_MARKETING
-
Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease
NCT04400864 ·Status: UNKNOWN ·Phase: NA
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04634643 ·Status: RECRUITING
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease
NCT06512701 ·Status: RECRUITING
-
Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.
NCT01696487 ·Status: COMPLETED ·Phase: NA
-
Impact Of Choline in Patients With NAFLD
NCT05200156 ·Status: UNKNOWN ·Phase: NA
-
Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD
NCT02929303 ·Status: APPROVED_FOR_MARKETING
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA